PreveCeutical Medical Inc.

  • ISIN: CA74141E1043
  • Land: .

Alle Mitteilungen

DGAP-News 04.05.20 19:37 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Possible Viral Prevention Program Usin[...]
DGAP-News 23.01.20 14:00 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Retains Patent Legal Team
DGAP-News 14.01.20 14:00 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Further Updates to the Successful Engi[...]
DGAP-News 08.01.20 14:00 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Positive Results Following a Prelimina[...]
DGAP-News 29.10.19 15:35 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Successful Completion from its Design,[...]
DGAP-News 07.10.19 14:04 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Receives $616,802 AUD Research and Development T[...]
DGAP-News 23.09.19 14:03 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces the Successful Engineering & Cell-Base[...]
DGAP-News 03.09.19 14:03 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Reaches Milestone in Research Program for Develo[...]
DGAP-News 06.08.19 21:19 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Grants Asterion Option to Purchase up to a 51% I[...]
DGAP-News 06.08.19 20:02 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Grants Asterion Option to Purchase up to a 51% I[...]
DGAP-News 09.07.19 14:03 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Successfully Incorporates Medicinal Cannabis Ext[...]
DGAP-News 17.06.19 14:03 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Further Positive Results from its Dual[...]
DGAP-News 03.06.19 14:03 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Secures $300,000 Loan and Resignation of a Director
DGAP-News 21.05.19 14:02 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Granted Approval to Acquire and Use Human Mucosa[...]
DGAP-News 17.04.19 16:37 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Partnership Leads to Two New Patent Filings
DGAP-News 15.04.19 14:32 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Files Application to Human Ethics Committee to A[...]
DGAP-News 10.04.19 14:32 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Further Results from its Preliminary S[...]
DGAP-News 08.04.19 15:37 DGAP-News: PreveCeutical Medical Inc.
PreveCeutical Announces Default Judgment Against JCN Capital Corp.
DGAP-News 04.04.19 20:42 DGAP-News: PreveCeutical Medical Inc.
Asterion Welcomes Australian Government Awarding of Major Proj[...]
DGAP-News 04.04.19 20:42 DGAP-News: PreveCeutical Medical Inc.
Asterion Welcomes Australian Government Awarding of Major Proj[...]

GBC-Fokusbox

Solutiance: Hohe Wachstumsdynamik durch den Ausbau des Plattformgeschäfts erwartet

Im ersten Halbjahr 2020 konnte Solutiance den eingeschlagenen Wachstumskurs fortsetzen und im Rahmen dessen die Gesamtleistung (Umsatz zzgl. Bestandsveränderungen) um rund 75 % auf 0,66 Mio. € (1. HJ 2019: 0,38 Mio. €) erhöhen. Das Unternehmen erwartet für das Gesamtjahr durch den weiteren Ausbau der softwarebasierten Dienstleistungen einen Umsatzsprung im Vergleich zum Vorjahr auf rund 3 Mio. €. Bei einem von uns ermittelten Kursziel von 4,85 € vergeben wir das Rating KAUFEN.

Aktuelle Research-Studie

amalphi AG

Original-Research: amalphi AG (von Sphene Capital GmbH): Buy

25. September 2020